Fasenra (benralizumab) has been approved by the US Food and Drug Administration (FDA) to treat adults with eosinophilic ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

In a clinical trial, nearly 60% of participants achieved remission and 41% fully tapered off oral corticosteroids.

EGPA, previously known as Churg-Strauss syndrome, is a rare inflammatory disorder characterized by asthma, necrotizing ...

AstraZeneca's Fasenra (benralizumab) has been approved by the US FDA for the treatment of eosinophilic granulomatosis with ...

EGPA, which was formerly known as Churg-Strauss syndrome, affects roughly 118,000 people worldwide and can often be ...

AstraZeneca’s FASENRA ® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 1 EGPA is a rare, immune-mediated ...

AstraZeneca PLC (AZN, AZN.L) announced Wednesday that its Fasenra (benralizumab) has been approved in the US for the treatment of ...

Actress and TV host Kris Aquino returned to the Philippines early Friday morning, after years of seeking treatment for her ...

Kris Aquino has returned to the Philippines after spending years abroad seeking treatment for her autoimmune conditions. The news of her homecoming was shared on social media, confirming her arrival ...

After two years, the Philippines' “Queen of All Media” Kris Aquino is back. In an Instagram post last Thursday (September 12) ...